NCT04606095 is a NA clinical trial of EEG in Fibromyalgia, sponsored by University of Michigan.

Who is sponsoring NCT04606095?

NCT04606095 is sponsored by University of Michigan.

What drugs are being tested in NCT04606095?

Interventions in NCT04606095: EEG, Neuroimaging EEG/fMRI (Aim 1), HD-tDCS treatments, Sham HD-tDCS treatments, Neuroimaging EEG/fMRI (Aim 3).

What condition does NCT04606095 study?

NCT04606095 studies Fibromyalgia, Healthy Volunteers.

Is NCT04606095 still recruiting?

NCT04606095 is currently recruiting now. Last updated 5 March 2026.

Last reviewed 2026-03-05 · How we verify

NCT04606095

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Explosive Synchronization of Brain Network Activity in Chronic Pain

Recruiting now NA Last updated 5 March 2026

What this trial tests

NA trial testing EEG in Fibromyalgia in 150 participants. Currently enrolling.

Timeline

13 November 2020

Primary endpoint
20 July 2026

20 July 2026

Quick facts

Lead sponsor	University of Michigan
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	150
Start date	13 November 2020
Primary completion	20 July 2026
Estimated completion	20 July 2026
Sites	1 location across United States

Drugs / interventions tested

EEG
Neuroimaging EEG/fMRI (Aim 1)
HD-tDCS treatments
Sham HD-tDCS treatments
Neuroimaging EEG/fMRI (Aim 3)

Conditions studied

Fibromyalgia — all drugs for Fibromyalgia →
Healthy Volunteers — all drugs for Healthy Volunteers →

Sponsor

University of Michigan

Who can join

Adults 19 to 74, any sex, with Fibromyalgia or Healthy Volunteers. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project is being conducted to evaluate the impact of explosive synchronization (ES) and its treatment with non-invasive brain stimulation in fibromyalgia (FM). The study design has three components, however, only 2 aims are enrolling participants. The first part (Aim1) is a cross sectional assessment of brain network explosive synchronization activity, connectivity, and response to pain in healthy controls and age and sex-matched fibromyalgia patients; the third part (Aim 3) is a longitudinal assessment of fibromyalgia patients undergoing one week of sham followed by high-definition transcranial direct current stimulation (HD-tDCS) of the motor cortex (M1) or one week of ES HD-tDCS of a brain region identified from computer modelling (Aim 2).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of EEG

Trials testing the same drug.

NCT04692922 — Prognostication of Recovery in Early Disorders of Consciousness Study · not yet recruiting
NCT07149974 — Neurofeedback Training for Autistic Children · NA · enrolling by invitation
NCT06867289 — Study of the Efficacy of Moderate Sedation With Intra-NAsal Dexmedetomidine Monitored by EEG MOnitoring · NA · recruiting
NCT06185257 — Electroencephalographic Changes in Nonconvulsive Children With Chronic Renal Disease · not yet recruiting
NCT06449794 — Neuropsycatric Disorders Among Children With Systemic Lupus Erythematosus in Sohag University Hospital · recruiting

Other recruiting trials for Fibromyalgia

Currently open trials in the same condition.

NCT02285868 — ATI Evidence-based Guide Investigating Clinical Services · active not recruiting
NCT07245303 — Neural Mechanisms of Light Driven Analgesia · NA · recruiting
NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
NCT07358754 — The Relationship Between Serum S100B and Brain-Derived Neurotrophic Factor · recruiting
NCT07465991 — The Effect of Digital Cognitive Behavioural Therapy for Insomnia on Physical Activity in Fibromyalgia · NA · recruiting

Other University of Michigan trials

Trials by the same sponsor.

NCT07536919 — Integrating Care for Hypertension-Diabetes MULTImorbidity in Guatemala Through HEARTS Implementation · NA · not yet recruiting
NCT05509842 — Function-based Accelerated Stimulation Therapy (FAST-therapy) for Freezing of Gait (FOG) After Parkinson's Disease (PD) · NA · not yet recruiting
NCT06311188 — Exploring PTSD Symptoms, Barriers and Facilitators to Mindfulness · NA · not yet recruiting
NCT07471646 — Effects of Ramadan Fasting With Exercise on Cardiometabolic Health · NA · not yet recruiting
NCT06671925 — A Community Health Worker-Led Program for Chronic Pain and Loneliness in Older Adults · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04606095 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Michigan
Last refreshed: 5 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04606095.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing